Short description
A Chapel Hill-based biotechnology company.
Description
Falcon Therapeutics Chapel Hill-based biotechnology company .The company is focused on developing a treatment of brain cancer with autologous neural stems cells that seek out and destroy cancer cells. It has filed two patents.
It was founded by Shawn Hingtgen, a professor in the Division of Molecular Pharmaceutics at the UNC-Chapel Hill Eshelman School of Pharmacy.
Total funding
$$2020202
Sign in for full access
Location
Chapel Hill, North Carolina, United States, North America
Founded on
January 1, 2015
Non-profit?
No
Acquired?
No
Employees count
11-50
Founders
Anna Seal